:: Library Catalog

Image de couverture de livre

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mamoor, Shahan
Format:	Recurso digital
Langue:
Publié:	Zenodo 2026
Accès en ligne:	https://doi.org/10.5281/zenodo.20225164
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

An expression screen to identify genes important for trastuzumab resistance: Ccl19.
par: Mamoor, Shahan
Publié: (2026)

An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
par: Mamoor, Shahan
Publié: (2026)

NLR family genes influence homeobox transcription factor expression.
par: Mamoor, Shahan
Publié: (2025)

Glucocorticoid resistance features changes in general transcription factor (GTF) expression.
par: Mamoor, Shahan
Publié: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
par: Mamoor, Shahan
Publié: (2025)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
par: Mamoor, Shahan
Publié: (2025)

Aire is a component gene of the Th17 gene signature.
par: Mamoor, Shahan
Publié: (2025)

Genes expressed in the CD4 + T lymphocyte.
par: Mamoor, Shahan
Publié: (2025)

Rip kinase expression during early development in humans.
par: Mamoor, Shahan
Publié: (2026)

ABCG2 functions in multi-drug resistance in human cancer in metastasis to the bone.
par: Mamoor, Shahan
Publié: (2025)

Ribosomal activation in TNBC resistance in vitro.
par: Mamoor, Shahan
Publié: (2025)

Unbiased discovery of genes required for pluripotency: Terf1.
par: Mamoor, Shahan
Publié: (2026)

TSC22D4 gene activation in Crohn's Disease.
par: Mamoor, Shahan
Publié: (2025)

ABCA12 functions in multi-drug resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)

Activation of ZIC family genes in CNS metastasis in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
par: Mamoor, Shahan
Publié: (2025)

Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
par: Mamoor, Shahan
Publié: (2025)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
par: Mamoor, Shahan
Publié: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
par: Mamoor, Shahan
Publié: (2026)

Telomerase control of Xist through Trf2.
par: Mamoor, Shahan
Publié: (2025)

SSX2IP induction in basal subtype breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Developmental stage-specific control of proliferation and senescence by EZH2.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: SKP2.
par: Mamoor, Shahan
Publié: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
par: Mamoor, Shahan
Publié: (2025)

BCL2L1 induction in metastasis to the brain in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: DNAI2.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
par: Mamoor, Shahan
Publié: (2025)